Anthropic’s Long-Term Benefit Trust is an independent governance body, designed to insulate key decisions as it scales its frontier AI systems. Narasimhan brings deep experience at the intersection of medicine, regulation, and global health. As the chief executive of Novartis, he has overseen the development and approval of more than 35 novel medicines.
from Tech-Economic Times https://ift.tt/YhJB2GW
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
The Devas shareholders are enforcing an International Chamber of Commerce arbitral award of $1.2 billion to Devas, owed by ISRO commercial a...
No comments:
Post a Comment